Table of Contents Global Rx Irritable Bowel Syndrome (IBS) Drugs Professional Survey Report Report 2022, Forecast to 2027 1 Market Study Overview 1.1 Study Objectives 1.2 Rx Irritable Bowel Syndrome (IBS) Drugs Introduce 1.3 Combined with the Analysis of Macroeconomic Indicators 1.4 Brief Description of Research Methods 1.5 Market Breakdown and Data Triangulation 2 Global Trend Summary 2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Segment by Type 2.1.1 IBS-D Drugs 2.1.2 IBS-C Drugs 2.1.3 Others 2.2 Market Analysis by Application 2.2.1 Women 2.2.2 Men 2.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Comparison by Regions (2017-2027) 2.3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2027) 2.3.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Status and Prospect (2017-2027) 2.3.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Status and Prospect (2017-2027) 2.3.4 Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Status and Prospect (2017-2027) 2.3.5 South America Rx Irritable Bowel Syndrome (IBS) Drugs Status and Prospect (2017-2027) 2.3.6 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Status and Prospect (2017-2027) 2.4 Basic Product Information 2.4.1 Basic Product Information & Technology Development History 2.4.2 Product Manufacturing Process 2.4.3 Interview with Major Market Participants 2.4.4 High-end Market Analysis and Forecast 2.5 Coronavirus Disease 2019 (Covid-19): Rx Irritable Bowel Syndrome (IBS) Drugs Industry Impact 2.5.1 Rx Irritable Bowel Syndrome (IBS) Drugs Business Impact Assessment - Covid-19 2.5.2 Market Trends and Rx Irritable Bowel Syndrome (IBS) Drugs Potential Opportunities in the COVID-19 Landscape 2.5.3 Measures / Proposal against Covid-19 3 Competition by Manufacturer 3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Market Share by Manufacturer (2017-2022) 3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Market Share by Manufacturer (2017-2022) 3.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Industry Concentration Ratio (CR5 and HHI) 3.4 Top 5 Rx Irritable Bowel Syndrome (IBS) Drugs Manufacturer Market Share 3.5 Top 10 Rx Irritable Bowel Syndrome (IBS) Drugs Manufacturer Market Share 3.6 Date of Key Manufacturers Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market 3.7 Key Manufacturers Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered 3.8 Mergers & Acquisitions Planning 4 Analysis of Rx Irritable Bowel Syndrome (IBS) Drugs Industry Key Manufacturers 4.1 Ironwood Pharmaceuticals 4.1.1 Company Details 4.1.2 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification 4.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.1.4 Main Business Overview 4.1.5 Ironwood Pharmaceuticals News 4.2 Sebela Pharmaceuticals 4.2.1 Company Details 4.2.2 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification 4.2.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.2.4 Main Business Overview 4.2.5 Sebela Pharmaceuticals News 4.3 Bausch Health 4.3.1 Company Details 4.3.2 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification 4.3.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.3.4 Main Business Overview 4.3.5 Bausch Health News 4.4 Takeda 4.4.1 Company Details 4.4.2 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification 4.4.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.4.4 Main Business Overview 4.4.5 Takeda News 4.5 Allergan 4.5.1 Company Details 4.5.2 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification 4.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.5.4 Main Business Overview 4.5.5 Allergan News 5 Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Categorized by Regions 5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Sales and Market Share by Regions 5.1.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Market Share by Regions (2017-2022) 5.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Market Share by Regions (2017-2022) 5.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 5.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 5.4 Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 5.5 South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 5.6 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 6 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Categorized by Countries 6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Revenue and Market Share by Countries 6.1.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) 6.1.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) 6.1.3 United States Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 6.1.4 Canada Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 6.1.5 Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 6.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (Value) by Manufacturers 6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Market Share by Type (2017-2022) 6.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2022) 7 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Categorized by Countries 7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Revenue and Market Share by Countries 7.1.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) 7.1.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) 7.1.3 Germany Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 7.1.4 UK Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 7.1.5 France Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 7.1.6 Russia Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 7.1.7 Italy Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 7.1.8 Spain Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 7.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (Value) by Manufacturers 7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Market Share by Type (2017-2022) 7.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2022) 8 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Categorized by Countries 8.1 Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Revenue and Market Share by Countries 8.1.1 Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) 8.1.2 Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) 8.1.3 China Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 8.1.4 South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 8.1.5 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 8.1.6 Australia Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 8.1.7 India Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 8.1.8 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 8.2 Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (Value) by Manufacturers 8.3 Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Market Share by Type (2017-2022) 8.4 Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2022) 9 South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Categorized by Countries 9.1 South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Revenue and Market Share by Countries 9.1.1 South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) 9.1.2 South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) 9.1.3 Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 9.2 South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Market Share by Type (2017-2022) 9.3 South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2022) 10 Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Categorized by Countries 10.1 Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales, Revenue and Market Share by Countries 10.1.1 Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) 10.1.2 Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) 10.1.3 GCC Countries Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 10.1.4 Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 10.1.5 Egypt Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 10.1.6 South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) 10.2 Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Market Share by Type 10.3 Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2022) 11 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Segment by Type 11.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Sales and Market Share by Type (2017-2022) 11.1.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Market Share by Type (2017-2022) 11.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Market Share by Type (2017-2022) 11.2 IBS-D Drugs Sales Growth Rate and Price 11.2.1 Global IBS-D Drugs Sales Growth Rate (2017-2022) 11.2.2 Global IBS-D Drugs Price (2017-2022) 11.3 IBS-C Drugs Sales Growth Rate and Price 11.3.1 Global IBS-C Drugs Sales Growth Rate (2017-2022) 11.3.2 Global IBS-C Drugs Price (2017-2022) 11.4 Others Sales Growth Rate and Price 11.4.1 Global Others Sales Growth Rate (2017-2022) 11.4.2 Global Others Price (2017-2022) 12 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Segment by Application 12.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2022) 12.2 Women Sales Growth Rate (2017-2022) 12.3 Men Sales Growth Rate (2017-2022) 13 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast 13.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Sales and Growth Rate (2022-2027) 13.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast by Regions (2022-2027) 13.2.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) 13.2.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) 13.2.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) 13.2.4 South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) 13.2.5 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) 13.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast by Type (2022-2027) 13.3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Forecast by Type (2022-2027) 13.3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share Forecast by Type (2022-2027) 13.4 Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast by Application (2022-2027) 13.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Forecast by Application (2022-2027) 13.4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share Forecast by Application (2022-2027) 14 Market Analysis 14.1.1 Market overview 14.1.2 Market Opportunities 14.1.3 Market Risk 14.1.4 Market Driving Force 14.1.5 Porter's Five Forces Analysis 14.1.6 SWOT Analysis 15 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Related Market Analysis 15.1 Upstream Analysis 15.1.1 Macro Analysis of Upstream Markets 15.1.2 Key Players in Upstream Markets 15.1.3 Upstream Market Trend Analysis 15.1.4 Rx Irritable Bowel Syndrome (IBS) Drugs Manufacturing Cost Analysis 15.2 Downstream Market Analysis 15.2.1 Macro Analysis of Down Markets 15.2.2 Key Players in Down Markets 15.2.3 Downstream Market Trend Analysis 15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures Figure Product Picture Rx Irritable Bowel Syndrome (IBS) Drugs Figure Market Concentration Ratio and Market Maturity Analysis of Rx Irritable Bowel Syndrome (IBS) Drugs Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Figure Part of Our External Database Figure Key Executives Interviewed Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type Figure Global Market Share of Rx Irritable Bowel Syndrome (IBS) Drugs by Type in 2021 Figure IBS-D Drugs Picture Figure IBS-C Drugs Picture Figure Others Picture Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (Volume) by Application Figure Women Picture Figure Men Picture Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Comparison by Regions (M USD) 2017-2027 Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (Million US$) (2017-2027) Figure North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (Million US$) Growth Rate (2017-2027) Figure Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (Million US$) Growth Rate (2017-2027) Figure Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (Million US$) Growth Rate (2017-2027) Figure South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (Million US$) Growth Rate (2017-2027) Figure Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (Million US$) Growth Rate (2017-2027) Table Business Impact Assessment - Covid-19 Table Market Trends and Rx Irritable Bowel Syndrome (IBS) Drugs Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Manufacturer (2017-2022) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Manufacturer in 2021 Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Manufacturer (2017-2022) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Manufacturer in 2021 Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Rx Irritable Bowel Syndrome (IBS) Drugs Manufacturer (Revenue) Market Share in 2021 Figure Top 10 Rx Irritable Bowel Syndrome (IBS) Drugs Manufacturer (Revenue) Market Share in 2021 Table Date of Key Manufacturers Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market Table Key Manufacturers Rx Irritable Bowel Syndrome (IBS) Drugs Product Type Table Mergers & Acquisitions Planning Table Ironwood Pharmaceuticals Company Profile Table Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification of Ironwood Pharmaceuticals Table Rx Irritable Bowel Syndrome (IBS) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ironwood Pharmaceuticals 2017-2022 Table Ironwood Pharmaceuticals Main Business Table Ironwood Pharmaceuticals Recent Development Table Sebela Pharmaceuticals Company Profile Table Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification of Sebela Pharmaceuticals Table Rx Irritable Bowel Syndrome (IBS) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sebela Pharmaceuticals 2017-2022 Table Sebela Pharmaceuticals Main Business Table Sebela Pharmaceuticals Recent Development Table Bausch Health Company Profile Table Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification of Bausch Health Table Rx Irritable Bowel Syndrome (IBS) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bausch Health 2017-2022 Table Bausch Health Main Business Table Bausch Health Recent Development Table Takeda Company Profile Table Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification of Takeda Table Rx Irritable Bowel Syndrome (IBS) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Takeda 2017-2022 Table Takeda Main Business Table Takeda Recent Development Table Allergan Company Profile Table Rx Irritable Bowel Syndrome (IBS) Drugs Product Introduction, Application and Specification of Allergan Table Rx Irritable Bowel Syndrome (IBS) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Allergan 2017-2022 Table Allergan Main Business Table Allergan Recent Development Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2022) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Regions (2017-2022) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Regions in 2021 Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Regions (2017-2022) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Regions in 2021 Figure North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2022) Table North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) Table North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries (2017-2022) Figure North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries in 2021 Table North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) Table North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries (2017-2022) Figure North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries in 2021 Figure United States Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Canada Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Table North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Manufacturer (2021) Figure North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Manufacturer in 2021 Table North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Type (2017-2022) Table North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Type (2017-2022) Table North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Application (2017-2022) Table North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Application (2017-2022) Figure Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2022) Table Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) Table Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries (2017-2022) Figure Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries in 2021 Table Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) Table Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries (2017-2022) Figure Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries in 2021 Figure Germany Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure UK Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure France Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Russia Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Italy Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Spain Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Table Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Manufacturer (2021) Figure Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Manufacturer in 2021 Table Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Type (2017-2022) Table Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Type (2017-2022) Table Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Application (2017-2022) Table Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Application (2017-2022) Figure Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2022) Table Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) Table Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries (2017-2022) Figure Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries in 2021 Table Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) Table Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries (2017-2022) Figure Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries in 2021 Figure China Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Japan Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Australia Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure India Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Table Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Manufacturer (2021) Figure Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Manufacturer in 2021 Table Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Type (2017-2022) Table Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Type (2017-2022) Table Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Application (2017-2022) Table Asia-pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Application (2017-2022) Figure South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2022) Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries (2017-2022) Figure South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries in 2019 Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries (2017-2022) Figure South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries in 2019 Figure Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Type (2017-2022) Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Type (2017-2022) Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2022) Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Type (2017-2022) Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Application (2017-2022) Table South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Application (2017-2022) Figure Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2022) Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales (Volume) by Countries (2017-2022) Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries (2017-2022) Figure Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Countries in 2019 Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Countries (2017-2022) Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries (2017-2022) Figure Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Countries in 2019 Figure GCC Countries Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure Egypt Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Figure South Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2017-2022) Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Type (2017-2022) Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Type (2017-2022) Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2022) Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Type (2017-2022) Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Application (2017-2022) Table Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales Share by Application (2017-2022) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Type (2017-2022) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Type (2017-2022) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Type in 2021 Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2022) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2017-2022) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type in 2019 Figure Global IBS-D Drugs Sales Growth Rate (2017-2022) Figure Global IBS-D Drugs Price (2017-2022) Figure Global IBS-C Drugs Sales Growth Rate (2017-2022) Figure Global IBS-C Drugs Price (2017-2022) Figure Global Others Sales Growth Rate (2017-2022) Figure Global Others Price (2017-2022) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales by Application (2017-2022) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2022) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application in 2021 Figure Global Women Sales Growth Rate (2017-2022) Figure Global Men Sales Growth Rate (2017-2022) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales and Growth Rate (2022-2027) Figure Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2022-2027) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Forecast by Regions (2017-2022) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share Forecast by Regions (2017-2022) Figure North America Sales Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) Figure Europe Sales Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) Figure Asia-Pacific Sales Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) Figure South America Sales Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) Figure Middle East & Africa Sales Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast (2022-2027) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Forecast by Type (2022-2027) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share Forecast by Type (2022-2027) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Sales Forecast by Application (2022-2027) Table Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share Forecast by Application (2022-2027) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Rx Irritable Bowel Syndrome (IBS) Drugs Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure Author List

Ironwood Pharmaceuticals Sebela Pharmaceuticals Bausch Health Takeda Allergan